Davide Schiffer, MD

Affiliations: 
Neuroscience University of Turin, Torino, Piemonte, Italy 
Google:
"Davide Schiffer"
Bio:

UNIV TURIN
DEPT OF NEUROSCIENCES
VIA CHERASCO 15
TORINO, 10126
Italy

Mean distance: 106866
 
Cross-listing: Neuropathology Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mellai M, Annovazzi L, Bisogno I, et al. (2020) Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas. Cells. 9: 1538
Schiffer D, Annovazzi L, Casalone C, et al. (2018) Glioblastoma: Microenvironment and Niche Concept. Cancers. 11: 5
Schiffer D, Mellai M, Boldorini R, et al. (2018) The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas International Journal of Molecular Sciences. 19: 2724
Schiffer D, Mellai M, Bovio E, et al. (2018) Glioblastoma niches: from the concept to the phenotypical reality. Neurological Sciences. 39: 1161-1168
Annovazzi L, Mellai M, Bovio E, et al. (2017) Microglia immunophenotyping in gliomas. Oncology Letters. 15: 998-1006
Schiffer D, Mellai M, Bovio E, et al. (2017) The neuropathological basis to the functional role of microglia/macrophages in gliomas. Neurological Sciences. 38: 1571-1577
Annovazzi L, Mellai M, Schiffer D. (2017) Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma Cancers. 9: 57
Schiffer D, Annovazzi L, Mellai M. (2017) A comprehensive view of tumor stem cells and their regulation by the microenvironment in glioblastoma Neurological Sciences. 38: 527-529
Mellai M, Annovazzi L, Senetta R, et al. (2017) Diagnostic revision of 206 adult gliomas (including 40 oligoastrocytomas) based on ATRX, IDH1/2 and 1p/19q status. Journal of Neuro-Oncology. 131: 213-222
Senetta R, Mellai M, Manini C, et al. (2016) Mesenchymal/radioresistant traits in granular astrocytomas: evidence from a combined clinical and molecular approach. Histopathology. 69: 329-337
See more...